Literature DB >> 23477516

Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers.

Diana Bell1, Ehab Y Hanna.   

Abstract

Sinonasal undifferentiated carcinoma is a highly aggressive lesion arising in the superior nasal cavity and paranasal sinuses. Differential diagnosis is wide because a range of similar lesions can present at this site. There is increasing evidence that sinonasal undifferentiated carcinoma is a surface (Schneiderian) epithelial-derived malignancy, with or without concurrent neuroendocrine differentiation. Prognosis is poor; recurrence with metastasis to lymph nodes and distant sites is frequent. A combination of radical surgery, chemotherapy and radiotherapy appears to provide the best chance of survival.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23477516     DOI： 10.1586/era.13.1

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


  10 in total

Review 1.  Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.

Authors:  Rami E Saade; Ehab Y Hanna; Diana Bell
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

Review 2.  Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

3.  Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.

Authors:  Diana Bell; Rami Saade; Dianna Roberts; Thomas J Ow; Michael Kupferman; Franco DeMonte; Ehab Y Hanna
Journal:  Head Neck Pathol       Date:  2014-05-08

Review 4.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

Review 5.  Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment.

Authors:  Mayur D Mody; Nabil F Saba
Journal:  Curr Treat Options Oncol       Date:  2020-01-16

Review 6.  High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling.

Authors:  Julie Guilmette; Peter M Sadow
Journal:  Arch Pathol Lab Med       Date:  2019-02-19       Impact factor: 5.534

7.  Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients.

Authors:  Marco Ferrari; Davide Mattavelli; Alberto Schreiber; Tommaso Gualtieri; Vittorio Rampinelli; Michele Tomasoni; Stefano Taboni; Laura Ardighieri; Simonetta Battocchio; Anna Bozzola; Marco Ravanelli; Roberto Maroldi; Cesare Piazza; Paolo Bossi; Alberto Deganello; Piero Nicolai
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

8.  Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience.

Authors:  Diana Bell; Ehab Y Hanna; Abbas Agaimy; Annikka Weissferdt
Journal:  Virchows Arch       Date:  2015-09-25       Impact factor: 4.064

Review 9.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 10.  Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.

Authors:  Piotr Czapiewski; Michał Kunc; Johannes Haybaeck
Journal:  Oncotarget       Date:  2016-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.